What is the debt of QuiaPEG Pharmaceuticals Holding this year?
QuiaPEG Pharmaceuticals Holding has a debt level of 20.51 SEK this year.
In 2024, QuiaPEG Pharmaceuticals Holding's total debt was 20.51 SEK, a 58.31% change from the 12.96 SEK total debt recorded in the previous year.
QuiaPEG Pharmaceuticals Holding's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.
Analyzing QuiaPEG Pharmaceuticals Holding's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.
Investors pay close attention to QuiaPEG Pharmaceuticals Holding’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.
Shifts in QuiaPEG Pharmaceuticals Holding’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.
QuiaPEG Pharmaceuticals Holding has a debt level of 20.51 SEK this year.
The debt of QuiaPEG Pharmaceuticals Holding has increased by 58.31% compared to the previous year increased.
High debt can pose a risk for investors of QuiaPEG Pharmaceuticals Holding, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.
Low debt means that QuiaPEG Pharmaceuticals Holding has a strong financial position and is able to fulfill its obligations without overburdening its finances.
An increase in debt of QuiaPEG Pharmaceuticals Holding can adversely affect the financial condition of the company and result in a higher burden on its finances.
A reduction in debt of QuiaPEG Pharmaceuticals Holding can strengthen the company's financial position and improve its ability to meet its financial obligations.
Some factors that can influence the debt of QuiaPEG Pharmaceuticals Holding include investments, acquisitions, operating costs, and revenue development.
The debts of QuiaPEG Pharmaceuticals Holding are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.
To change the debt, QuiaPEG Pharmaceuticals Holding can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.
Over the past 12 months, QuiaPEG Pharmaceuticals Holding paid a dividend of 5.15 SEK . This corresponds to a dividend yield of about 28,600 %. For the coming 12 months, QuiaPEG Pharmaceuticals Holding is expected to pay a dividend of 0 SEK.
The current dividend yield of QuiaPEG Pharmaceuticals Holding is 28,600 %.
QuiaPEG Pharmaceuticals Holding pays a quarterly dividend. This is distributed in the months of June, July, April, April.
QuiaPEG Pharmaceuticals Holding paid dividends every year for the past 0 years.
For the upcoming 12 months, dividends amounting to 0 SEK are expected. This corresponds to a dividend yield of 0 %.
QuiaPEG Pharmaceuticals Holding is assigned to the 'Health' sector.
To receive the latest dividend of QuiaPEG Pharmaceuticals Holding from 4/5/2017 amounting to 5.55 SEK, you needed to have the stock in your portfolio before the ex-date on 3/30/2017.
The last dividend was paid out on 4/5/2017.
In the year 2023, QuiaPEG Pharmaceuticals Holding distributed 0 SEK as dividends.
The dividends of QuiaPEG Pharmaceuticals Holding are distributed in SEK.
Our stock analysis for QuiaPEG Pharmaceuticals Holding Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of QuiaPEG Pharmaceuticals Holding Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.